de Vathaire_Br J Cancer_1997
Initiatives
-
To study the risks of solid tumours and leukaemia after
administration of Iodine 131.
*Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
- Start Year
- 1989
- End Year
- 1995
- Funding
- e Association pour la Recherche sur le Cancer, the Ligue Nationale Contre le Cancer (Comites de la Mame, des Ardennes et de l'Aube), the Fondation de France (Leg Doris Levy), COGEMA and FRAMATOME. Cecilia Francese received a fellowship from the Program of Radioprotection of the European Communities (no. B 17-913002).
| Investigators | Contacts |
|---|---|
|
Design
- Study design
- Patients' cohort
- Follow Up
- Mean follow-up of 10 years,
- Supplementary Information
Marker Paper
de Vathaire, F; Schlumberger, M; Delisle, MJ; Francese, C; Challeton, C; de la Genardiére, E; Meunier, F; Parmentier, C; Hill, C; Sancho-Garnier, H (1997). Leukaemias and cancers following iodine-131 administration for thyroid cancer. British Journal of Cancer, 75(5), 734–739. doi:10.1038/bjc.1997.130
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 1,771
- Number of participants with biosamples
- Supplementary Information
- Patients treated for a differentiated thyroid cancer in the two participating institutions between 1950 and December 1989 were studied.
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |